California Senate Bill SB983

California 2019-2020 Regular Session

• Introduced: 2/12/20
• Refer: 2/20/20

Caption

Unused medications: cancer medication recycling.

Impact

The bill modifies existing state laws regarding medication distribution by allowing for the donation and redistribution of cancer medications. By facilitating medication recycling, the bill is expected to increase access to necessary treatments for cancer patients, potentially reducing treatment costs and alleviating medication shortages. The establishment of a registry for participating practitioners aims to maintain accountability and enhance reporting standards within the program. This may lead to a more efficient use of resources in California's healthcare system.

Summary

Senate Bill 983, also known as the Cancer Medication Recycling Act, aims to establish a framework for the collection and distribution of unused cancer medications. This act empowers medical practitioners to accept donated cancer medications from patients and redistribute them to other patients within their practice. To participate in this program, practitioners must be registered with the Medical Board of California, thereby creating a controlled and documented environment for medication donation and redistribution. The bill outlines the responsibilities of practitioners, including maintaining records and ensuring proper storage of donated medications.

Contention

While proponents of SB 983 advocate for its potential to improve access to cancer treatments and reduce waste, there are notable concerns regarding safety and accountability. Critics argue that the redistribution of medications could pose risks if not properly managed, with fears about the regulatory oversight required to ensure the quality and safety of redistributed drugs. The bill includes provisions that protect donors and practitioners from liability when acting in good faith, but opponents worry about the implications of such exemptions and the necessity of thorough compliance with medical standards.